Lazareva E B, Zalogueva G V, Nikiforova L N
Klin Lab Diagn. 1994(1):50-1.
Ninety-seven enterobacterial isolates from patients were identified parallel by Enterotest and MMT E1, a new test system developed in Russia. Enterotest helped identify 97% of enterobacterial strains, MMT E1 86.6%. The results coincided in 83.5% of cases. Enterotest system often failed to demonstrate reaction to phenylalanine, this impeding Proteus identification. Some tests failed in MMT E1 as well. Elimination of these shortcomings will improve the reliability of the test systems and permit their wider use at practical clinical microbiology laboratories.
采用俄罗斯研发的新型检测系统MMT E1和肠杆菌检测法对97株来自患者的肠杆菌分离株进行了同步鉴定。肠杆菌检测法可鉴定出97%的肠杆菌菌株,MMT E1为86.6%。在83.5%的病例中,结果一致。肠杆菌检测系统常常无法显示出对苯丙氨酸的反应,这妨碍了变形杆菌的鉴定。MMT E1也存在一些检测失败的情况。消除这些缺点将提高检测系统的可靠性,并使其能在实际临床微生物实验室中得到更广泛的应用。